{"data":{"id":"us-sd/sdcl-58-17h-51","jurisdiction":"us-sd","citation":"SDCL § 58-17H-51","heading":"Reclassification of benefits with respect to cancer treatment medications.","body":"A health carrier may not reclassify benefits with respect to cancer treatment medications or increase a copayment, deductible, or coinsurance amount for covered cancer treatment medications that are injected or intravenously administered unless:\n(1) The increase is applied generally to other medical or pharmaceutical benefits covered under the plan and is not done to circumvent § 58-17H-50;\n(2) The reclassification of benefits with respect to cancer treatment medications is done in a manner that is consistent with §§ 58-17H-50 to 58-17H-52, inclusive; or\n(3) A health carrier is applying cost-sharing increases consistent with the annual increases in the cost of health care.","path":["TITLE 58. INSURANCE","CHAPTER 58-17H. UTILIZATION REVIEW AND BENEFIT DETERMINATIONS"],"source_url":"https://sdlegislature.gov/Statutes/58-17H-51","current_through":"2026-08-31","vintage":"","retrieved_at":"2026-09-03T15:18:57Z","sha256":"6b0a05b1af8bae3afb359296a40c12fe0bdf86c44db73c498e557f0e573d0a58","source_id":"us-sd","stale":true,"prev":"us-sd/sdcl-58-17h-50","next":"us-sd/sdcl-58-17h-52"},"notice":"GroundRules: Original legal text. Not legal advice."}